| HOME >> BIOLOGY >> TECHNOLOGY |
MONMOUTH JUNCTION, N.J., July 18, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that Andrea ("Andi") Holtzman Drucker, J.D. has been appointed to the newly created position of Senior Vice President, General Counsel and Corporate Secretary, effective as of July 18, 2011. Ms. Drucker, who will report directly to Timothy Whitten, President and Chief Executive Officer of Insmed, will provide strategic legal and business advice for various operational aspects of the Company.
Ms. Drucker brings more than 25 years of legal experience in the biotechnology and pharmaceutical industries to Insmed. Most recently, she served as Senior Vice President, General Counsel and Secretary, for PuriCore plc, a publicly-traded biotechnology company, where she advised the executive management and board of directors on company legal matters. Prior to that, she spent two years with Practical Business Solutions, a private legal consulting firm, during which she served as Acting General Counsel for Novavax, Inc., and as Interim Associate General Counsel for Auxilium Pharmaceuticals, Inc., both publicly-traded biotechnology companies, advising the companies on legal matters, including licensing, research and development, intellectual property rights, and FDA regulations. Ms. Drucker began her career at FMC Corporation, a publicly-traded diversified chemicals company, where she spent 17 years serving in a number of positions, including as Group Counsel for the company's Specialty Chemicals Group, FMC BioPolymer.
"Andi has a distinguished track record of providing strategic legal counsel to growing companies, like Insmed," said Mr. Whitten. "Her extensive experience with the regulatory and commercial aspects of the pharmaceutical and biotechnology industries, as well as the protection of intellectual property and SEC compliance issues, make her an important addition to our manag
'/>"/>
| SOURCE Insmed Incorporated Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
2. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
3. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
4. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
5. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
6. Amicus Therapeutics Joins Russell 3000® Index
7. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
8. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
9. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
10. William T. Boehm Joins Neogens Board of Directors
11. Scott Garrett Joins Water Street Healthcare Partners
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |